Laboratory Corporation of America Holdings and Sequenom, Inc.

Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE:LH), the world’s leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ: SQNM), a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, today announced that they have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.

Morrow Sodali is acting as Information Agent on this merger.

Click here to request documents for this deal.